Ocera Therapeutics Inc (OCRX.OQ)

OCRX.OQ on NASDAQ Stock Exchange Global Market

30 Jul 2014
Price Change (% chg)

$0.04 (+0.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for OCRX.OQ


Ocera Therapeutics, Inc., formerly Tranzyme, Inc., is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders. The Company is developing TZP-102, an oral ghrelin agonist for treating the... (more)


Beta: --
Market Cap (Mil.): $106.90
Shares Outstanding (Mil.): 19.72
Dividend: --
Yield (%): --


  OCRX.OQ Industry Sector
P/E (TTM): -- 35.68 36.12
EPS (TTM): -0.77 -- --
ROI: -73.64 18.88 18.15
ROE: -73.82 19.60 18.97
Search Stocks

MARKET PULSE-Bancorp, Biofuel, Boeing, Ocera, Orexigen

NOTE TO SUBSCRIBERS: Reuters is converting some short-form coverage of hot stocks, including Market Pulse, into the new Stocks Buzz product. From June 16, items that were previously published only as a compilation will be published as standalone items featuring the BUZZ tag. They will also be accessible via the STXBZ news code. A collated version will continue to appear on the WATCH/US named-item code under the headline "BUZZ-U.S. stocks on the move".

11 Jun 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks